Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
9.685 USD | +5.27% | +6.32% | +19.49% |
09/05 | RBC Cuts Price Target on IGM Biosciences to $20 From $21, Keeps Outperform, Speculative Risk | MT |
08/05 | Earnings Flash (IGMS) IGM BIOSCIENCES Posts Q1 Collaboration Revenue $497,000 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.49% | 543M | |
+5.90% | 111B | |
+11.60% | 106B | |
-12.80% | 22.24B | |
-0.06% | 21.25B | |
-4.97% | 18.97B | |
-35.21% | 18.52B | |
-11.41% | 16.81B | |
+38.07% | 12.54B | |
-24.58% | 8.09B |
- Stock Market
- Equities
- IGMS Stock
- News IGM Biosciences, Inc.
- JPMorgan Chase Adjusts Price Target on IGM Biosciences to $26 From $27, Maintains Neutral Rating